TWICE THERAPEUTICS Trademark
Serial Number: 98319744
TWICE THERAPEUTICS is a trademark filed by
James Dahlman
on December 18, 2023. The trademark is classified under Class 42 (Computer & Scientific).
The application is currently pending registration.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Mark J. Liss LEYDIG, VOIT & MAYER, LTD.
TWO PRUDENTIAL PLAZA, 180 N. STETSON AVE
SUITE 4900
CHICAGO, IL 60601
United States
Trademark Details
Filing Date
December 18, 2023
Registration Date
Not Registered
Published for Opposition
November 12, 2024
Goods & Services
Biotech research and product development in the field of RNA therapeutics
Filing History
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 10, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jun 9, 2026 EX3G
SOU EXTENSION 3 FILED
Jun 9, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 9, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 16, 2025 EX2G
SOU EXTENSION 2 FILED
Dec 16, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jun 9, 2025 EX1G
SOU EXTENSION 1 FILED
Jun 9, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 9, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 24, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 2, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 2, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 2, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 2, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 18, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 18, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 18, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 17, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2024 NWOS
NEW APPLICATION ENTERED
Dec 18, 2023 NWAP
